Cancer stories
GlycoSyn is seeking new global customers for kifunensine, a key ingredient in the manufacture of a drug for the treatment of rare genetic disorders.
The largest study of its kind has found no link between childhood cancer and cellphone mast exposure during pregnancy.
A 10-year study involving 13 countries, including New Zealand, into possible links between cellphone use and cancer will be published next week.
